TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23364373

Group type: EXPERIMENTAL
Intervention: Ketamine + Atropine (0.01 mg/kg)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ketamine + Placebo (distilled water)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ketamine + Atropine
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ketamine + Placebo
Number of subjects: 200
Study: 22193788

Group type: EXPERIMENTAL
Intervention: Weekly feedback to clinicians
Number of subjects: 340

Group type: COMPARATOR
Intervention: Feedback every 90 days (control)
Number of subjects: 340
Study: 19667976

Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil (GEn) 1200 mg
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil (GEn) 600 mg
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 17941782

Group type: EXPERIMENTAL
Intervention: Laparoscopic donor nephrectomy (LDN)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Open donor nephrectomy (ODN)
Number of subjects: 40
Study: 15234478

Group type: EXPERIMENTAL
Intervention: Hypertonic saline injection (acute pain)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Isotonic saline injection (fear of pain)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Unpredictable electric shocks (fear of impending pain)
Number of subjects: 12
Study: 12812861

Group type: EXPERIMENTAL
Intervention: PTSD patients
Number of subjects: 23

Group type: COMPARATOR
Intervention: Healthy comparison subjects
Number of subjects: 23

Group type: COMPARATOR
Intervention: PTSD patients and controls
Number of subjects: 23
Study: 11542706

Group type: EXPERIMENTAL
Intervention: Lower Body Negative Pressure (LBNP) group, subjected to -30 mm Hg for 1 hour per day during the last week of HDT.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (CON) without LBNP.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both groups (LBNP and CON) during HDT.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both groups after LBNP.
Number of subjects: 12
Study: 7566020

Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg each evening)
Number of subjects: 6595
Study: 2190884

Group type: EXPERIMENTAL
Intervention: High-dose cyclophosphamide (HD-CTX) with rhGM-CSF (5.5 micrograms/kg/day by continuous iv infusion for 14 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-dose cyclophosphamide (HD-CTX) without rhGM-CSF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose cyclophosphamide (HD-CTX) with rhGM-CSF
Number of subjects: 0
Study: 474381

Group type: EXPERIMENTAL
Intervention: GIK (30% glucose solution with 50 units of regular insulin and 80 mM KCl per liter, 50 mol. bolus followed by 1 ml./Kg./hr.)
Number of subjects: 9

Group type: COMPARATOR
Intervention: NSS (normal saline, 50 mol. bolus followed by 1 ml./Kg./hr.)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (no infusion)
Number of subjects: 9
Study: 31789800

Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation (supervised exercise therapy) in addition to standard care (10 days of prednisolone, general information, and counseling)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Standard care (10 days of prednisolone, general information, and counseling)
Number of subjects: 65
Study: 31596723

Group type: EXPERIMENTAL
Intervention: On-Pump CABG
Number of subjects: 60

Group type: COMPARATOR
Intervention: Off-Pump CABG
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (On-Pump and Off-Pump CABG)
Number of subjects: 60
Study: 28804046

Group type: EXPERIMENTAL
Intervention: Pneumatic machine (Pn)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Plate-loaded machine (PL)
Number of subjects: 36
Study: 25487899

Group type: EXPERIMENTAL
Intervention: Clipped axilla
Number of subjects: 85

Group type: COMPARATOR
Intervention: Unclipped axilla
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gluconate surgical preparation
Number of subjects: 85
Study: 23521510

Group type: EXPERIMENTAL
Intervention: High-frequency skin ultrasonography (Derma Scan Cortex Technology, version 3)
Number of subjects: 16
Study: 21603893

Group type: EXPERIMENTAL
Intervention: Ketamine (100 ng/ml blood plasma level)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19358171

Group type: EXPERIMENTAL
Intervention: Defunctioning stoma
Number of subjects: 11429
Study: 17394048

Group type: EXPERIMENTAL
Intervention: Oral polyethylene glycol lavage solution and enemas (group A)
Number of subjects: 97

Group type: COMPARATOR
Intervention: No preparation (group B)
Number of subjects: 97
Study: 15338804

Group type: EXPERIMENTAL
Intervention: Mild persistent asthma management
Number of subjects: 400

Group type: COMPARATOR
Intervention: Daily symptoms
Number of subjects: 400

Group type: COMPARATOR
Intervention: Medical intervention for asthma flares
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Asthma symptoms and beta-agonist use
Number of subjects: 400
Study: 11705298

Group type: EXPERIMENTAL
Intervention: Pergolide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bromocriptine
Number of subjects: 0
Study: 9555777

Group type: EXPERIMENTAL
Intervention: Oral d-sotalol
Number of subjects: 3121

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 3121
Study: 7568678

Group type: EXPERIMENTAL
Intervention: 37% phosphoric acid etching (group 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 10% maleic acid etching (group 2)
Number of subjects: 60
Study: 30995230

Group type: EXPERIMENTAL
Intervention: Malaria
Number of subjects: 817

Group type: EXPERIMENTAL
Intervention: Meningitis
Number of subjects: 817

Group type: EXPERIMENTAL
Intervention: Sepsis
Number of subjects: 817

Group type: EXPERIMENTAL
Intervention: Streptococcus pneumoniae infections
Number of subjects: 817

Group type: EXPERIMENTAL
Intervention: Malnutrition
Number of subjects: 817

Group type: EXPERIMENTAL
Intervention: Gastro-enteritis / diarrhoea
Number of subjects: 817

Group type: EXPERIMENTAL
Intervention: Anaemia
Number of subjects: 817

Group type: EXPERIMENTAL
Intervention: HIV
Number of subjects: 817
Study: 28168303

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 2 mg/kg Q3W
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 10 mg/kg Q3W
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 10 mg/kg Q2W
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Pembrolizumab in patients with PD-L1 TPS ≥50%
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 101
Study: 26177957

Group type: EXPERIMENTAL
Intervention: Meal-mediated electrical stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Implantation of DIAMOND device (placebo effect)
Number of subjects: 0
Study: 23883162

Group type: EXPERIMENTAL
Intervention: Anma massage therapy (40-min session once weekly for 2 months, total of 8 sessions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no Anma massage sessions, followed by medical doctors)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Anma massage therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 21910213

Group type: EXPERIMENTAL
Intervention: Romiplostim
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 19637289

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (4 weeks of aerobic cycling exercise)
Number of subjects: 19
Study: 16458680

Group type: EXPERIMENTAL
Intervention: Laser treatment (12 argon spots)
Number of subjects: 145
Study: 15023378

Group type: EXPERIMENTAL
Intervention: 800mg chondroitin sulfate (CS) per day for two periods of 3 months during 1 year
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 800mg chondroitin sulfate (CS)
Number of subjects: 120
Study: 11182624

Group type: EXPERIMENTAL
Intervention: Aspirin therapy initiated within 24 hours after the onset of symptoms of an acute MI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin in patients with prior occlusive cardiovascular disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin in primary prevention trials
Number of subjects: 0
Study: 9270582

Group type: EXPERIMENTAL
Intervention: Sad thoughts (self-induced sadness)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Happy thoughts (self-induced happiness)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Mental counting (control condition)
Number of subjects: 14
Study: 8309674

Group type: EXPERIMENTAL
Intervention: Prostacyclins
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3711368

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interpersonal psychotherapy
Number of subjects: 0
Study: 29411112

Group type: EXPERIMENTAL
Intervention: xenogenic graft plus modified perforated collagen membrane (MPM)
Number of subjects: 15

Group type: COMPARATOR
Intervention: xenogenic graft plus standard collagen membrane (CM)
Number of subjects: 15
Study: 27221288

Group type: EXPERIMENTAL
Intervention: Graduated extinction
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Bedtime fading
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sleep education control
Number of subjects: 43
Study: 24986183

Group type: EXPERIMENTAL
Intervention: Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) among older adults
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cohort-based ADL and IADL disparities
Number of subjects: 0
Study: 20960029

Group type: EXPERIMENTAL
Intervention: Trabectedin with dexamethasone
Number of subjects: 41

Group type: COMPARATOR
Intervention: Trabectedin with placebo
Number of subjects: 41
Study: 21189693

Group type: EXPERIMENTAL
Intervention: Excellent glycemic control (HbA1c 6.74 +/- 0.16%)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fair glycemic control (HbA1c 8.45 +/- 0.30%)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Uncontrolled state (HbA1c 10.08 +/- 0.48%)
Number of subjects: 30
Study: 18786230

Group type: EXPERIMENTAL
Intervention: 20 microg teriparatide (PTH 1‐34) daily subcutaneous injections
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 16006746

Group type: EXPERIMENTAL
Intervention: Sitting position during GMA recording
Number of subjects: 17

Group type: COMPARATOR
Intervention: Recumbent position during GMA recording
Number of subjects: 17
Study: 12439652

Group type: EXPERIMENTAL
Intervention: Stepped-care behavioral intervention
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 120
Study: 10366917

Group type: EXPERIMENTAL
Intervention: PCA (84 hips)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Harris-Galante (87 hips)
Number of subjects: 155
Study: 7673655

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Methylscopolamine
Number of subjects: 14
Study: 2143597

Group type: EXPERIMENTAL
Intervention: Ramipril alone (2.5-5 mg/day)
Number of subjects: 661

Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg
Number of subjects: 661

Group type: EXPERIMENTAL
Intervention: Ramipril 5 mg in combination with furosemide 20 mg
Number of subjects: 661

Group type: COMPARATOR
Intervention: Placebo (during run-in period)
Number of subjects: 661
Study: 6993652

Group type: EXPERIMENTAL
Intervention: Tetracycline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31974670

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Early cord clamping (C)
Number of subjects: 70
Study: 30782957

Group type: EXPERIMENTAL
Intervention: Revealed criteria for placental insufficiency
Number of subjects: 0

Group type: COMPARATOR
Intervention: Concealed criteria for placental insufficiency
Number of subjects: 0
Study: 30412115

Group type: EXPERIMENTAL
Intervention: In Plane (IP) technique
Number of subjects: 34

Group type: COMPARATOR
Intervention: Out of Plane (OOP) technique
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 34
Study: 27178856

Group type: EXPERIMENTAL
Intervention: Standard EEG assessment
Number of subjects: 73
Study: 25143337

Group type: EXPERIMENTAL
Intervention: Cyclosporine (3 mg/kg per day for 8 weeks)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Acitretin (0.3-0.5 mg/kg per day for 8 weeks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group not applicable
Number of subjects: 46
Study: 22539829

Group type: EXPERIMENTAL
Intervention: Online postdilution hemodiafiltration (n=358)
Number of subjects: 714

Group type: COMPARATOR
Intervention: Low-flux hemodialysis (n=356)
Number of subjects: 714
Study: 18670465

Group type: EXPERIMENTAL
Intervention: timolol maleate 0.5%
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: brimonidine tartrate 0.2%
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: travoprost 0.004%
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 54
Study: 17045810

Group type: EXPERIMENTAL
Intervention: Form-related words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semantically related words
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral condition
Number of subjects: 0
Study: 15495698

Group type: EXPERIMENTAL
Intervention: Bed rest as a therapy
Number of subjects: 0
Study: 11239726

Group type: EXPERIMENTAL
Intervention: Contingency management (CM) procedures providing incentives for specific behaviors
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Contingency management (CM) procedures
Number of subjects: 46
Study: 9231668

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy regimen for M0 patients
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy regimen for M+ patients
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy regimen for M1 patients
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy regimen for M2 patients
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy regimen for M3 patients
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Patients who failed treatment
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 188
Study: 8433239

Group type: EXPERIMENTAL
Intervention: Whole cow milk (WCM)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Formula
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Pooled analysis of all feeding groups
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: WCM
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: WCM and Formula
Number of subjects: 104
Study: 2821636

Group type: EXPERIMENTAL
Intervention: Contraceptive sponge
Number of subjects: 255

Group type: COMPARATOR
Intervention: No sponge (Control)
Number of subjects: 255
Study: 31415254

Group type: EXPERIMENTAL
Intervention: Randomized control trials
Number of subjects: 131
Study: 29561278

Group type: EXPERIMENTAL
Intervention: Lung-protective ventilation (LPV group) [tidal volume 5 ml/kg ideal body weight + PEEP between 5 and 8 cmH2O]
Number of subjects: 346

Group type: COMPARATOR
Intervention: Nonprotective ventilation (control group) [tidal volume 10 ml/kg ideal body weight without PEEP]
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Lung-protective ventilation (LPV group)
Number of subjects: 346

Group type: COMPARATOR
Intervention: Nonprotective ventilation (control group)
Number of subjects: 346
Study: 27108261

Group type: EXPERIMENTAL
Intervention: Posterior decompression, bone cement augmentation and internal fixation (n=14)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Only posterior decompression combined with internal fixation (n=14)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Experimental group (n=14)
Number of subjects: 28
Study: 24346151

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy
Number of subjects: 31

Group type: COMPARATOR
Intervention: Ultrasound therapy
Number of subjects: 31
Study: 22692326

Group type: EXPERIMENTAL
Intervention: Enhanced image group (n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Common image group (n=30)
Number of subjects: 60
Study: 20883734

Group type: EXPERIMENTAL
Intervention: Implementation-intention group
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 57
Study: 17525884

Group type: EXPERIMENTAL
Intervention: Exercise group (E) - home-based walking program, aerobic walking at target heart rate for 20 minutes or more daily, 2 or more days a week
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (C) - normal level of activity
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Exercise group (E) - home-based walking program
Number of subjects: 200
Study: 16084884

Group type: EXPERIMENTAL
Intervention: Laparoscopic electrocautery of the ovaries
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ovulation induction with recombinant FSH (rFSH)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Clomiphene citrate (CC) treatment
Number of subjects: 32
Study: 12100806

Group type: EXPERIMENTAL
Intervention: Behavioral therapy (six weekly instructional sessions on bladder training and individualized voiding schedules)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Control group (no instruction, kept urinary diaries for 6 weeks)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Behavioral therapy (after 6 weeks for all women)
Number of subjects: 152
Study: 10344481

Group type: EXPERIMENTAL
Intervention: Moisturizer applied on one arm/hand 3x daily for 9 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Untreated control on the other arm/hand
Number of subjects: 12
Study: 8744965

Group type: EXPERIMENTAL
Intervention: Intentional learning encoding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generating responses during intentional encoding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aggregate item JOLs
Number of subjects: 0
Study: 1851692

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 12
Study: 7316527

Group type: EXPERIMENTAL
Intervention: Once-daily ultraviolet radiation treatment with coal tar
Number of subjects: 9

Group type: COMPARATOR
Intervention: Twice-daily ultraviolet radiation treatment with coal tar
Number of subjects: 9
Study: 31006575

Group type: COMPARATOR
Intervention: Annual school-based treatment with albendazole
Number of subjects: 150000

Group type: EXPERIMENTAL
Intervention: Annual community-wide treatment with albendazole
Number of subjects: 150000

Group type: EXPERIMENTAL
Intervention: Biannual community-wide treatment with albendazole
Number of subjects: 150000
Study: 27810407

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided continuous PV catheter with a continuous infusion of 0.2% ropivacaine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Single-shot intercostal blocks (ICB)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided continuous PV catheter
Number of subjects: 48
Study: 25828982

Group type: EXPERIMENTAL
Intervention: Aftercare services (treatment follow-up, family psychoeducation, patient social skills training)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 120
Study: 24521524

Group type: EXPERIMENTAL
Intervention: Childhood sexual abuse
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Childhood physical abuse
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Childhood emotional abuse
Number of subjects: 280
Study: 21930734

Group type: EXPERIMENTAL
Intervention: Methotrexate monotherapy (target dose 20 mg/week)
Number of subjects: 147
Study: 19923530

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch (0, 5, 10, or 15 mg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 17322146

Group type: EXPERIMENTAL
Intervention: FBT 400 microg (transmucosal)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: FBT 800 microg (oral)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: OTFC 800 microg (transmucosal)
Number of subjects: 26

Group type: COMPARATOR
Intervention: FBT compared to OTFC
Number of subjects: 26
Study: 15223196

Group type: EXPERIMENTAL
Intervention: Damage to the superior colliculus contralateral to the cortical lesion
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Additional damage to right superior colliculus
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Reduced right tecto-pulvinar activity
Number of subjects: 1
Study: 11578785

Group type: EXPERIMENTAL
Intervention: Orlistat combined with hypocaloric diet and moderate physical exercise
Number of subjects: 3305

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3305
Study: 9608291

Group type: EXPERIMENTAL
Intervention: Generic substitute for fluphenazine decanoate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Original product of fluphenazine decanoate
Number of subjects: 0
Study: 7982862

Group type: EXPERIMENTAL
Intervention: Behavioral intervention program for sleep disturbances
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (matched controls)
Number of subjects: 28
Study: 2863289

Group type: EXPERIMENTAL
Intervention: Celiprolol 200 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Celiprolol 400 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Terbutaline (0.5 mg)
Number of subjects: 12
Study: 30021540

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral based online group intervention for adolescents (Op Koers Online)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral based online group intervention for parents (Op Koers Online)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral based online group intervention for adolescents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral based online group intervention for parents
Number of subjects: 0
Study: 27539168

Group type: EXPERIMENTAL
Intervention: Financial incentives (up to $1,650) for biochemically verified abstinence at 1, 2, and 3 weeks, and 1, 3, and 6 months.
Number of subjects: 805

Group type: COMPARATOR
Intervention: Booklets plus access to a smoking cessation website (control group).
Number of subjects: 805